SCHEMBL3760091

SCHEMBL3760091

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3ccnc(-c4cccc(CC(=O)N5CC(N)C5)c4)c3)c2C1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.33
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33
CTSS P25774 1/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PIK3CA P42336 5/20 0.33
AKT1 P31749 1/20 0.33
AOC3 Q16853 6/20 0.33
BUB1 O43683 1/20 0.32
KDM1A O60341 1/20 0.32
HDAC1 Q13547 1/20 0.32
PIK3CD O00329 3/20 0.32
PIK3CB P42338 3/20 0.32
PIK3CG P48736 3/20 0.32
KDM4E B2RXH2 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764960 0.95 CTSK (0.34) CTSKCTSLCTSBCTSSALDH1A1
SCHEMBL3767336 0.92 POLB (0.35) CTSKCTSLCTSBCTSSALDH1A1
SCHEMBL3766704 0.91 BUB1 (0.34) CTSKCTSLCTSBCTSSALDH1A1
SCHEMBL3765767 0.90 PIK3CA (0.36) ALDH1A1MAPTSMN1; SMN2PIK3CAAOC3
SCHEMBL3762352 0.89 PIK3CA (0.37) ALDH1A1PIK3CABUB1KDM1AHDAC1
SCHEMBL3765171 0.89 SYK (0.35) CTSKCTSLCTSBCTSSALDH1A1
SCHEMBL3761960 0.89 BUB1 (0.37) ALDH1A1MAPTSMN1; SMN2PIK3CAAOC3
SCHEMBL14080349 0.88 BUB1 (0.31) ALDH1A1MAPTSMN1; SMN2PIK3CAAOC3
SCHEMBL3769096 0.88 ALDH1A1 (0.34) ALDH1A1MAPTSMN1; SMN2PIK3CAAOC3
SCHEMBL3766079 0.88 SYK (0.34) CTSKCTSLCTSBCTSSBUB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA CTSK 1003/4885CTSL 4214/4885CTSB 2756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.